申请人:Pliant Therapeutics, Inc.
公开号:US20190276449A1
公开(公告)日:2019-09-12
The invention relates to compounds of formula (A) and formula (I):
or a salt thereof, wherein R
1
, R
2
, R
10
, R
11
, R
12
, R
13
, R
14
, R
15
, R
16
, q and p are as described herein. Compounds of formula (A), formula (I), and pharmaceutical compositions thereof are αvβ6 integrin inhibitors that are useful for treating fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
该发明涉及以下化合物的公式(A)和公式(I):或其盐,其中R1、R2、R10、R11、R12、R13、R14、R15、R16、q和p如本文所述。公式(A)、公式(I)的化合物及其药物组合物是αvβ6整合素抑制剂,可用于治疗纤维化疾病,如特发性肺纤维化(IPF)和非特异性间质性肺炎(NSIP)。